Philip Morris
Fields
- Author
- Friedman, M.
- Document File
- 2023131044/2023131192/Missing
- Type
- LETT, LETTER
- Area
- CARCHMAN,RICHARD/MEZZANINE
- Characteristic
- ILLE, ILLEGIBLE
- MARG, MARGINALIA
- Named Organization
- Wall Street Journal
- Natl Heart Lung + Blood Inst
- Board of Directors
- Journal of the American Medical Assn
- Natl Heart Lung + Blood Inst
- Site
- R530
- Master ID
- 2023131143/1146
Related Documents: - Request
- Stmn/R1-009
- Named Person
- Sirridge, P.M.
- Cooper, T.
- Carchman, R.
- Charles, J.
- Friedman, M.
- Cooper, T.
- Litigation
- Stmn/Produced
- Author (Organization)
- Meyer Friedman Inst
- Mount Zion Medical Center
- Univ of Ca San Francisco
- Mount Zion Medical Center
- Recipient
- Wall, C.R.
- Recipient (Organization)
- PM, Philip Morris
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- vie78e00
Document Images
.
. . . s::.~a.: :.ti v~~... ,.. , r. .. + : =o-~:. _ . ... . . _ . ~. . a...:a.: . . . . . ~. .
._ ...
BOARD OF DIRECTORS
( II 11Kw14\
(~: . w ..
,.:'. . +,. . ...
1.\1 N..~1.
_1a\IYa4n++,1'+.wa .,_+../ Na\.
..w/ ..
. ~1.+~+1. ... .1.. .. p, .1 . .1...
v.rw.nv a 1 .v..
w//..nl n+Y.rv14..
ILY11,Va.\\1.14! i
Fin \I I: 1..:+1.
u1P1.rLIEIwrwl
r.Iw/w1/M/r /4
K.wYr 11 11,._
. II VYV \\.. IM 1 1\1. 1 11.1 +..N I Y'.
11 Mr4.\ .\La IN1. .,.1. 1 11\ 1'.++/1 N I Y
If,\,\\wb ,...n.val..w
!Ir+~la /1,....
rY1 W..1
1+/ YYN r Ir.+r4... w'.w.
A. ~/n.. I / . A...
/! 11YV.\
\\//Yr ,\V11\\14
K.+.rM11 1..~._
I~ISVI /,\ Iw. ,/N 1
D..YIN \lil.a.
a ualwiw..v1.1 J+yNI..
arawl/rnwlr Yal\//r1Ula4
1\.111rA W+.Y.
aN11t/vPlw1 nnn1Y.
aIN1YIAa.rfla+lalr:n
D,.,1.D K.Nn.an'l //111 . IM/ /.. IMI.N 1\/
\hl \: /Nn V/lwl .1 , 1\IIY+. l, 4
C J,1 w.Yl K,n.a,. w. a.
111.1YV,\ a\I,tlll/l /\Itl IIt/.Y/NIY
t; a l./\.111V//I I\ IIYIYI~.. 1\t
rrlw..w. awlan 14
h'Yn.wK il....
_..r.. ,
L,:/LV (\. tH,:, -
I,/\C.IIt.,N, n4s/1ra
.\I,aIIN/.aY.114..Y1N/M
.WYr,\N1111r4.Vi/\il\\V /1\Ir~1YlIt.1\t
C.N/t, T/YOV\-Ill:
IlrO.w~1Y:/1Rl,IN,\ .11,t~a lrta..1
_/~\\Nr1+1 \I\/YVII.
-,[\I/Rn VUI/q.11 a{wl/Y'./rtaa V'
Rr...A.(1.au I/NY'
IYIVLF\1 ,\/+.I/wf:I,NL11.fYrtIN'4M
\1/~ 1\a
{.1\willl'.~./\++/N/Y: V 1~
\r'l\r/rhVhlr,1.1111Y1r1t4
Cl1S%t.l.TA\T"; T(tT11E P(T1K1)
C:.. .1,..1..f7 IY1Vf».1
,Nr1Mrlfa rYr ..wr
fl..ar,FeLU..
I\,1.141C,.
MKV1NIrrM Ilr/raY1r\IN,\.
nf.l c V l./ h/«~II a A luu Ihlw aNr1K A
111Fti11M\LYrTYfIN
IIMNFli1 rAl [I~(.llNJ/\\I
lRever -friPbman lttgritute
Muunt Linn.Mktilical Center oi UC San Francisco
I n57 Scott Street
Madin- A.1dre5.: P.O. Box i921
,an Franci.co. California 94120
1 415) 885-7426
CORONARY/CANCER PREVENTION PROJECT
December 17, 1991
1aR:TYtIFIIICAL DIKECT(7R
K.Yra+. f sr+YU.n. V.U:
Atty. Charles R. Wall
Vice President and Associate General Counsel
Philip Morris Companies, Inc.
320 Park Aven>_:e
New York, NY 10017
My dear Charles:
I am enclosing a list of those donors whose funds have
been used to help us set up the Coronary/Cancer
Prevention Project. We obtained these funds initially
to get a wider base of support for the project so that
no one could or ever would say that only Philip Morris
financed this research project:
Also, at the present time, the various corporations
which helped us enroll the 3,700 participants into the
study have made available to us rooms in which 1,500
of this cohort can hold group sessions. Since all of
our counseling is done after corporate hours, the
security and janitorial services necessary for us to
use these rooms after work hours have been donated.
This is one of the reasons that this thirteen to
fourteen year project will only cost $1,000,000 a year
and'not $140,000,000 as was spent in the Multiple Risk
Factor Intervention Trial (MRFIT) over its ten year
extent. I can hope, too, that the Coronary/Cancer
Prevention Project will not be labeled as was the MRFIT
project which was described as "a debacle" by The Wall
Street Journal.
At our Board'' of Directors meeting last week, it was
also.pointed out, after your letter was read to them,
that this research project was never presented to any
corporation as a benefit to their employees but rather
as a possible benefit to humanity. This is because
only our type of study can indicate whether emotional
stress is playing a part in the pathogenesis of
coronary heart disease and cancer. I am reasonably
sure that it will be considered, in the long haul, one
of the landmark clinical studies of this century. That
this expectation is not unreasonable is indicated by
the fact that the Journal of the American Medical
.`' ~.
~~ A
- X
f'~~ NOW
I .'\ 4 `ii
Vv~ .v- yit 1, 1 v
V
t w~ rKf~t~xT ~\D
.
i'~ /\.
aaa111rrrFFF
CI E\GCLTIYE10FK'F+.
t yy.Vf
.~1 IAFD1C.lL1)IKFCTC)R
~A1 ~IIVrIYr1,V,\4.1..

Atty. Charles R. Wall
December 17, 1991
Page 2
Association in listing the one hundred most important publications
in its one hundred year history of publishing listed our 1959 and
1964 research projects among these one hundred. Indeed, the 1959
announcement of the relationship of Type A behavior to coronary
heart disease ranked as number twelve in the one hundred articles.
I also am enclosing a letter from Dr. Ted Cooper which I intended
to show you folks when you were out here. Coming from a tough
med~cal director of the National Heart, Lung & Blood Institute (if
there ever was one), I consider it quite a compliment. I think it
possible that he may again give us a contribution, as he did in
1988 when he was apprised of our receiving the grant from Philip
Morris.
Sincerely yours,
~1'.Tk
Meyer Friedman, M.D.
Medical Director
MF/dpr
Enc.
